POLL RESULTS OF THE ANNUAL GENERAL MEETINGHELD ON JUNE 26, 2024

B_table indent_3.5 mm N_table indent_3 mm 维亚生物科技控股集团 Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take 用简体 no responsibility for the contents of this announcement make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement. 李向荣 _荣字用简体 (Incorporated in the Cayman Islands as an exempted company with limited liability) (Stock code: 1873) POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON JUNE 26 2024 The Board announces that all the resolutions as set out in the Notice were duly passed by the Shareholders as ordinary resolutions/special resolution by way of poll at the Annual General Meeting.The board of directors (the “Board”) of VIVA BIOTECH HOLDINGS (the “Company”) is pleased to announce the poll results of the annual general meeting of the Company (the “Annual General Meeting”) held at Meeting Room A615 735 Ziping Road Zhoupu Town Pudong New District Shanghai PRC on Wednesday June 26 2024 at 10:00 a.m..Reference is made to the Company’s circular (the “Circular”) in connection with the Annual General Meeting and notice of the Annual General Meeting (the “Notice”) dated April 29 2024. Unless the context requires otherwise capitalized terms used in this announcement shall have the same meanings as those defined in the Circular.The voting results in respect of the resolutions proposed at the Annual General Meeting were as follows: Number of Votes (%) Ordinary Resolutions For Against 1. To receive and adopt the audited consolidated financial 1122413111 17366501 statements of the Company and its subsidiaries and the reports (98.48%) (1.52%) of the directors and auditor for the year ended December 31 2023. 2. (a) To re-elect Mr. Ren Delin as executive director of the 1122979612 16800000 Company; (98.53%) (1.47%) (b) To re-elect Mr. Wang Stephen Hui as non-executive 1122979612 16800000 director of the Company; (98.53%) (1.47%) (c) To re-elect Mr. Fu Lei as independent non-executive 1122979612 16800000 director of the Company; (98.53%) (1.47%) (d) T o r e - e l e c t M s . L i X i a n g r o n g a s i n d e p e n d e n t 1122931112 16848500 non-executive director of the Company; (98.52%) (1.48%) – 1 –B_table indent_3.5 mm N_table indent_3 mm维亚生物科技控股集团 Number of Votes (%) 用简体 Ordinary Resolutions For Against 3. To authorise the board of directors of the Company to fix the 1122979612 16800000 李向荣 _荣字 remuneration of all the directors. (98.53%) (1.47%) 用简体 4. To re-appoint Ernst & Young as auditor of the Company and 1122979612 16800000 authorise the board of directors of the Company to fix their (98.53%) (1.47%) remuneration. 5. (A) To give a general mandate to the directors of the 1107393623 32385989 Company to allot issue or deal with additional shares (97.16%) (2.84%) (including any sale or transfer of treasury shares out of the treasury that are held as treasury shares of the Company) not exceeding 20% of the issued share capital of the Company as at the date of this resolution. (B) To give a general mandate to the directors of the 1122979612 16800000 Company to repurchase shares not exceeding 10% of the (98.53%) (1.47%) issued share capital of the Company as at the date of this resolution (excluding any treasury shares). (C) To extend the authority given to the directors of the 1107393623 32385989 Company pursuant to ordinary resolution no. 5(A) to (97.16%) (2.84%) issue shares (including any sale or transfer of treasury shares out of the treasury that are held as treasury shares of the Company) by adding to the issued share capital of the Company the number of shares repurchased under ordinary resolution no. 5(B).As more than 50% of the votes were cast in favour of each of the above resolutions all the resolutions were passed as ordinary resolutions at the Annual General Meeting.Number of Votes (%) Special Resolution For Against 6. To adopt the third amended and restated memorandum and 1122979612 16800000 articles of association of the Company. (98.53%) (1.47%) As more than 75% of the votes were cast in favour of the above resolution it was passed as a special resolution at the Annual General Meeting.Please refer to the Notice for the full text of the resolutions proposed at the Annual General Meeting.– 2 –B_table indent_3.5 mm N_table indent_3 mm维亚生物科技控股集团 The total number of issued Shares as at the date of the Annual General Meeting was 2161366305用简体 Shares which was the total number of Shares entitling the Shareholders to attend and vote for or against all resolutions. As at the date of the Annual General Meeting there were (i) no treasury shares held by the Company (including any treasury shares held or deposited with the Central Clearing and Settlement 李向荣 _荣字 System established and operated by Hong Kong Securities Clearing Company Limited) and as such no用简体 voting rights of treasury shares have been exercised at the Annual General Meeting; and (ii) no Shares repurchased by the Company which are pending cancellation and should be excluded from the total number of issued Shares for the purpose of the Annual General Meeting. There were no Shares entitling the holders to attend and abstain from voting in favour at the Annual General Meeting as set out in rule 13.40 of the Listing Rules. There were no restrictions on any Shareholders casting votes on any of the proposed resolutions at the Annual General Meeting. No person was required under the Listing Rules to abstain from voting on the resolutions proposed at the Annual General Meeting and no party has stated its intention in the Circular to vote against or to abstain from voting the resolutions proposed at the Annual General Meeting.Tricor Investor Services Limited the Hong Kong branch share registrar and transfer office of the Company was appointed as the scrutineer for the vote-taking at the Annual General Meeting. The Executive Directors Mr. Mao Chen Cheney Mr. Wu Ying and Mr. Ren Delin the Non-executive Directors Mr. Wu Yuting and Mr. Wang Stephen Hui and the Independent Non-executive Directors Mr. Fu Lei Ms. Li Xiangrong and Mr. Wang Haiguang attended and participated in the Annual General Meeting either in-person or by electronic means.By order of the Board VIVA BIOTECH HOLDINGS Mao Chen Cheney Chairman and Executive Director Hong Kong June 26 2024 As at the date of this announcement the Board comprises three Executive Directors namely Mr. Mao Chen Cheney (Chairman) Mr. WU Ying and Mr. Ren Delin; two Non-executive Directors namely Mr. WU Yuting and Mr. Wang Stephen Hui; and three Independent Non-executive Directors namely Mr. Fu Lei Ms. Li Xiangrong and Mr. Wang Haiguang.–3–